Literature DB >> 18629267

In vitro gene expression dissected: chemostat surgery for mycobacterium tuberculosis.

Brian W James1, Joanna Bacon, Tobias Hampshire, Kim Morley, Philip D Marsh.   

Abstract

A unique approach, combining defined and reproducible in vitro models with DNA microarrays, has been developed to study environmental modulation of mycobacterial gene expression. The gene expression profiles of samples of Mycobacterium tuberculosis, from independent chemostat cultures grown under defined and reproducible conditions, were found to be highly correlated. This approach is now being used to study the effect of relevant stimuli, such as limited oxygen availability, on mycobacterial gene expression. A modification of the chemostat culture system, enabling large-volume controlled batch culture, has been developed to study starvation survival. Cultures of M. tuberculosis have been maintained under nutrient-starved conditions for extended periods, with 10(6) - 10(7) bacilli surviving in a culturable state after 100 days. The design of the culture system has made it possible to control the environment and collect multiple time-course samples to study patterns of gene expression. These studies demonstrate that it is possible to perform long-term studies and obtain reproducible expression data using controlled and defined in vitro models.

Entities:  

Year:  2002        PMID: 18629267      PMCID: PMC2448431          DOI: 10.1002/cfg.184

Source DB:  PubMed          Journal:  Comp Funct Genomics        ISSN: 1531-6912


  9 in total

Review 1.  Monitoring gene expression using DNA microarrays.

Authors:  C A Harrington; C Rosenow; J Retief
Journal:  Curr Opin Microbiol       Date:  2000-06       Impact factor: 7.934

Review 2.  DNA microarrays: translational tools for understanding the biology of Mycobacterium tuberculosis.

Authors:  C E Barry; B G Schroeder
Journal:  Trends Microbiol       Date:  2000-05       Impact factor: 17.079

3.  Isolation of genomic DNA from mycobacteria.

Authors:  J T Belisle; M G Sonnenberg
Journal:  Methods Mol Biol       Date:  1998

4.  An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.

Authors:  L G Wayne; L G Hayes
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Exploring the metabolic and genetic control of gene expression on a genomic scale.

Authors:  J L DeRisi; V R Iyer; P O Brown
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

6.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.

Authors:  D R Sherman; M Voskuil; D Schnappinger; R Liao; M I Harrell; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

7.  The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium.

Authors:  B W James; A Williams; P D Marsh
Journal:  J Appl Microbiol       Date:  2000-04       Impact factor: 3.772

8.  Influence of iron-limited continuous culture on physiology and virulence of Legionella pneumophila.

Authors:  B W James; W S Mauchline; R B Fitzgeorge; P J Dennis; C W Keevil
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog.

Authors:  A F Cunningham; C L Spreadbury
Journal:  J Bacteriol       Date:  1998-02       Impact factor: 3.490

  9 in total
  2 in total

Review 1.  Dormancy models for Mycobacterium tuberculosis: A minireview.

Authors:  Amani M Alnimr
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

2.  Re-growth of Mycobacterium tuberculosis populations exposed to antibiotic combinations is due to the presence of isoniazid and not bacterial growth rate.

Authors:  Charlotte L Hendon-Dunn; Henry Pertinez; Alice A N Marriott; Kim Hatch; Jon C Allnutt; Geraint Davies; Joanna Bacon
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.